Macleods Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is RASAGILINE MESYLATE, with a corresponding US DMF Number 26706.
Remarkably, this DMF maintains an Active status since its submission on December 24, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 06, 2014, and payment made on September 26, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II